Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
|
US |
|
Chemed Corp
NYSE:CHE
|
US |
|
A
|
Alibaba Group Holding Ltd
OTC:BABAF
|
CN |
|
Spir Group ASA
OSE:SPIR
|
NO |
|
F
|
FL Entertainment NV
AEX:FLE
|
FR |
|
Midland Exploration Inc
OTC:MIDLF
|
CA |
|
C
|
Corning Inc
F:GLW
|
US |
|
Khiron Life Sciences Corp
XTSX:KHRN
|
CA |
|
B
|
BTS Group Holdings PCL
SET:BTS
|
TH |
Wall St Price Targets
SUPN Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for SUPN is 64.09 USD with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUPN's stock price target?
Price Target
64.09
USD
According to Wall Street analysts, the average 1-year price target for SUPN is 64.09 USD with a low forecast of 55.55 USD and a high forecast of 69.3 USD.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
61%
The compound annual growth rate for Operating Income over the next 8 years is 61%.
